MedPath

Nortriptyline

Generic Name
Nortriptyline
Brand Names
Aventyl, Pamelor
Drug Type
Small Molecule
Chemical Formula
C19H21N
CAS Number
72-69-5
Unique Ingredient Identifier
BL03SY4LXB

Overview

Nortriptyline hydrochloride, the active metabolite of amitriptyline, is a tricyclic antidepressant (TCA). It is used in the treatment of major depression and is also used off-label for chronic pain and other conditions.

Background

Nortriptyline hydrochloride, the active metabolite of amitriptyline, is a tricyclic antidepressant (TCA). It is used in the treatment of major depression and is also used off-label for chronic pain and other conditions.

Indication

Nortriptyline is indicated for the relief of the symptoms of major depressive disorder (MDD). Some off-label uses for this drug include treatment of chronic pain, myofascial pain, neuralgia, and irritable bowel syndrome.

Associated Conditions

  • Chronic Pain
  • Irritable Bowel Syndrome (IBS)
  • Major Depressive Disorder (MDD)
  • Myofascial Pain Syndrome
  • Pain, Orofacial
  • Postherpetic Neuralgia

FDA Approved Products

Nortriptyline Hydrochloride
Manufacturer:Preferred Pharmaceuticals Inc
Route:ORAL
Strength:50 mg in 1 1
Approved: 2023/08/15
NDC:68788-7216
Nortriptyline Hydrochloride
Manufacturer:REMEDYREPACK INC.
Route:ORAL
Strength:25 mg in 1 1
Approved: 2024/02/13
NDC:70518-0708
Nortriptyline Hydrochloride
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:75 mg in 1 1
Approved: 2020/11/02
NDC:71335-2199
Nortriptyline Hydrochloride
Manufacturer:PD-Rx Pharmaceuticals, Inc.
Route:ORAL
Strength:25 mg in 1 1
Approved: 2024/03/25
NDC:43063-897
Nortriptyline Hydrochloride
Manufacturer:Proficient Rx LP
Route:ORAL
Strength:50 mg in 1 1
Approved: 2023/03/01
NDC:63187-759

Singapore Approved Products

APO-NORTRIPTYLINE CAPSULE 10 mg
Manufacturer:APOTEX INC
Form:CAPSULE
Strength:10 mg
Online:Yes
Approved: 1997/03/18
Approval:SIN09255P
APO-NORTRIPTYLINE CAPSULE 25 mg
Manufacturer:APOTEX INC
Form:CAPSULE
Strength:25 mg
Online:Yes
Approved: 1997/03/18
Approval:SIN09253P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath